EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging

Dave Singh, Nicolas Roche iD, Libo Wu, Hosein Sadafi, Jan De Backer, Navid Monshi Tousi iD, Jonathan Marshall

International Journal of Chronic Obstructive Pulmonary Disease · 2025-06 · Volume 20 · 2103-2116

DOI: 10.2147/copd.s510214 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025-06. Verfasst von Dave Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Research Group, University of Manchester, Medicines Evaluation Unit, Manchester University National Health Service Foundation Trust, Manc…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lung, Bronchodilator Agents, Computer Simulation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: AstraZeneca, Boehringer Ingelheim, GSK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveLungBronchodilator AgentsComputer SimulationGlycopyrrolateMuscarinic AntagonistsAdrenergic beta-2 Receptor AgonistsGlucocorticoidsHumansAdministration, InhalationBeclomethasoneBenzyl AlcoholsChlorobenzenesAgedFormoterol FumarateMaleMetered Dose InhalersDrug CombinationsDry Powder InhalersFemaleAndrostadienesMiddle AgedQuinuclidinesBudesonideTissue DistributionTomography, X-Ray ComputedAerosolsModels, Biological

Stichwörter der Autor:innen

chronic obstructive pulmonary diseasefunctional respiratory imagingsingle-inhaler triple therapysmall airways

Substanzen

Bronchodilator AgentsBeclomethasoneBenzyl AlcoholsChlorobenzenesGlycopyrrolateFormoterol Fumaratevilanterolfluticasone furoateDrug CombinationsAndrostadienes

Autor:innen und Institutionen

  • Respiratory Research Group, University of Manchester, Medicines Evaluation Unit, Manchester University National Health Service Foundation Trust, Manchester, UK.
  • Department of Respiratory Medicine, Hospital Cochin, APHP Centre, Paris, France.
  • Université Paris Cité, Institut Cochin, U1016, Paris, France.
  • Product Development Operations, AstraZeneca, Durham, NC, USA.
  • Department of Computational Engineering, FLUIDDA NV, Kontich, Belgium.
  • FLUIDDA NV, Kontich, Belgium.

ORCID-Profile: Nicolas Roche, Navid Monshi Tousi

Förderung

  • AstraZeneca
  • Boehringer Ingelheim
  • GSK
  • Novartis
  • Pfizer

Zitieren

APA

Singh, D., Roche, N., Wu, L., Sadafi, H., De Backer, J., Monshi Tousi, N., & Marshall, J. (2025). In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging. International Journal of Chronic Obstructive Pulmonary Disease, Volume 20, 2103-2116. https://doi.org/10.2147/copd.s510214

Vancouver

Singh D, Roche N, Wu L, Sadafi H, De Backer J, Monshi Tousi N, et al. In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging. International Journal of Chronic Obstructive Pulmonary Disease. 2025;Volume 20:2103-2116. doi:10.2147/copd.s510214

BibTeX
@article{Singh2025,
  author = {Singh, Dave and Roche, Nicolas and Wu, Libo and Sadafi, Hosein and De Backer, Jan and Monshi Tousi, Navid and Marshall, Jonathan},
  title = {In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  volume = {Volume 20},
  pages = {2103--2116},
  doi = {10.2147/copd.s510214}
}
Kostenlos starten →